blu-701
Showing 1 - 1 of 1
Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)
Recruiting
- Lung Neoplasm
- +26 more
- BLU-701
- +3 more
-
Boston, Massachusetts
- +6 more
Jun 23, 2022